Emily L. Heil

Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections

Pranita D. Tamma, Emily L. Heil, Julie Ann Justo et al. · Clinical Infectious Diseases · 2024 · 940 citations

Life Sciences, Infectious Diseases, Microbiology +16

Infectious Diseases Society of America Position Paper: Recommended Revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Sepsis Quality Measure

Chanu Rhee, Kathleen Chiotos, Sara E. Cosgrove et al. · Clinical Infectious Diseases · 2020 · 203 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +17

Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance

Jeffrey R. Strich, Emily L. Heil, Henry Masur · The Journal of Infectious Diseases · 2020 · 141 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections

Madeline King, Emily L. Heil, Safia Kuriakose et al. · Antimicrobial Agents and Chemotherapy · 2017 · 132 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study

Jason C Gallagher, Michael J. Satlin, Abdulrahman Elabor et al. · Open Forum Infectious Diseases · 2018 · 130 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +15